Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
Sarepta
Sarepta
Press Releases
3 Drugs Receiving Accelerated Approval from the FDA and Reviewed by the Office of Inspector General Raised Concerns
Press Releases
Sarepta Reiterated Total Net Product Revenue of $3.0 Billion in 2025
Editorials
Turkish DMD Patients Who are Eligible for Exon 51 Skipping Treatment (Eteplirsen) Request Their Medications from the Ministry of Health
Approved Treatments
Frequently Asked Questions About Eteplirsen (Exondys 51) for DMD Treatment
Research
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
Editorials
In Which Countries Is Elevidys Approved? Is Elevidys Approved In Europe?
Editorials
First Girl in the World to Receive Elevidys Gene Therapy: Raniya Scott
Approved Treatments
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
1
2
3
Page 3 of 3
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
DMD
Micro Dystrophin: 5 Critical Questions Everyone Is Thinking About
Press Releases
SonoThera Ultrasound-Mediated Delivery Method Can Deliver Full-Length Dystrophin to Cells
Press Releases
Scribe Therapeutics and Prevail Therapeutics to Share In Vivo CRISPR-based Genome Editing Data at ASGCT 2025
